Close Window

Digital Look Email A Friend

Syncona investment sells cancer study assets to AstraZeneca for $12m

Published by Frank Prenesti on 27th December 2024

(Sharecast News) - Life science investor Syncona said its investment Achilles Therapeutics has sold cancer study assets to AstraZeneca for $12m (£9.58m).

URL: http://www.digitallook.com/dl/news/story/34778769/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.